Cargando…

Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2

Human coronaviruses (HCoVs), including severe acute respiratory syndrome coronavirus (SARS-CoV) and 2019 novel coronavirus (2019-nCoV, also known as SARS-CoV-2), lead global epidemics with high morbidity and mortality. However, there are currently no effective drugs targeting 2019-nCoV/SARS-CoV-2. D...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Yadi, Hou, Yuan, Shen, Jiayu, Huang, Yin, Martin, William, Cheng, Feixiong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Singapore 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073332/ https://www.ncbi.nlm.nih.gov/pubmed/32194980 http://dx.doi.org/10.1038/s41421-020-0153-3

Ejemplares similares

Structural, glycosylation and antigenic variation between 2019 novel coronavirus (2019-nCoV) and SARS coronavirus (SARS-CoV)
por: Kumar, Swatantra, et al.
Publicado: (2020)

Return of the Coronavirus: 2019-nCoV
por: Gralinski, Lisa E., et al.
Publicado: (2020)

2019 Novel Coronavirus (2019-nCoV) Pneumonia
por: Liu, Peng, et al.
Publicado: (2020)

Containing 2019-nCoV (Wuhan) coronavirus
por: Kaplan, Edward H.
Publicado: (2020)

Novel Coronavirus (2019-nCoV) in Disguise
por: Zhang, Qian, et al.
Publicado: (2020)

Emerging 2019 Novel Coronavirus (2019-nCoV) Pneumonia
por: Song, Fengxiang, et al.
Publicado: (2020)

Origins of MERS-CoV, and lessons for 2019-nCoV
por: Ji, John S
Publicado: (2020)

Coronavirus : du nCoV au MERS-CoV
por: D., Y.-M.
Publicado: (2013)

Composition of human-specific slow codons and slow di-codons in SARS-CoV and 2019-nCoV are lower than other coronaviruses suggesting a faster protein synthesis rate of SARS-CoV and 2019-nCoV
por: Yang, Chu-Wen, et al.
Publicado: (2020)

Comparison of Real‐Q 2019‐nCoV and DaAn Gene 2019‐nCoV polymerase chain reaction assays for the detection of SARS‐CoV‐2
por: Marembo, Takudzwa, et al.
Publicado: (2021)

Drug Repurposing: Dipeptidyl Peptidase IV (DPP4) Inhibitors as Potential Agents to Treat SARS-CoV-2 (2019-nCoV) Infection
por: Rao, Praveen P. N., et al.
Publicado: (2021)

Comparison of the SARS-CoV-2 (2019-nCoV) M protein with its counterparts of SARS-CoV and MERS-CoV species
por: Alharbi, Sultan Nafea, et al.
Publicado: (2021)

SARS-CoV, MERS-CoV, and 2019-nCoV viruses: an overview of origin, evolution, and genetic variations
por: Krishnamoorthy, Sarayu, et al.
Publicado: (2020)

Applying fixed point methods and fractional operators in the modelling of novel coronavirus 2019-nCoV/SARS-CoV-2
por: Panda, Sumati Kumari
Publicado: (2020)

The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
Publicado: (2020)

CT Imaging of the 2019 Novel Coronavirus (2019-nCoV) Pneumonia
por: Lei, Junqiang, et al.
Publicado: (2020)

CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV)
por: Chung, Michael, et al.
Publicado: (2020)

The emotional impact of Coronavirus 2019-nCoV (new Coronavirus disease)
por: Lima, Carlos Kennedy Tavares, et al.
Publicado: (2020)

CT-Verlauf einer Coronavirus(2019-nCoV)-Pneumonie
por: Jin, Qianna, et al.
Publicado: (2020)

Note from the editors: novel coronavirus (2019-nCoV)
Publicado: (2020)

Puzzle of highly pathogenic human coronaviruses (2019-nCoV)
por: Li, Jing, et al.
Publicado: (2020)

Coronavirus 2019-nCoV: Is the genie already out of the bottle?
por: Hanscheid, Thomas, et al.
Publicado: (2020)

The coronavirus 2019-nCoV epidemic: Is hindsight 20/20?
por: Malta, Monica, et al.
Publicado: (2020)

A case of 2019-nCoV novel coronavirus outbreak
por: Fatima, Asma, et al.
Publicado: (2021)

Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations
por: Cao, Yanan, et al.
Publicado: (2020)

An update on the 2019-nCoV outbreak
por: Ammad Ud Din, Mohammad, et al.
Publicado: (2020)

Pandemic potential of 2019-nCoV
por: Thompson, Robin
Publicado: (2020)

Emerging understandings of 2019-nCoV
por: The Lancet
Publicado: (2020)

2019-nCoV: Polite with children!
por: Caselli, Désirée, et al.
Publicado: (2020)

Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019-nCoV
por: Lee, Ping-Ing, et al.
Publicado: (2020)

Diagnostic evaluation of nCoV-QS, nCoV-QM-N, and nCoV-OM detection kits based on rRT-PCR for detection of SARS-CoV-2 in Ecuador
por: Salinas, Marco, et al.
Publicado: (2022)

2019 novel coronavirus (2019-nCoV) outbreak: A new challenge
por: Lupia, Tommaso, et al.
Publicado: (2020)

Inefficiency of Sera from Mice Treated with Pseudotyped SARS-CoV to Neutralize 2019-nCoV Infection
por: Liu, Zezhong, et al.
Publicado: (2020)

The Allplex 2019-nCoV (Seegene) assay: which performances are for SARS-CoV-2 infection diagnosis?
por: Farfour, Eric, et al.
Publicado: (2020)

In response to: "Diagnostic evaluation of nCoV-QS, nCoV-QM-N, and nCoV-OM detection kits based on rRT-PCR for detection of SARS-CoV-2 in Ecuador"
por: Garcia-Bereguiain, Miguel Angel
Publicado: (2023)

2019_nCoV/SARS‐CoV‐2: rapid classification of betacoronaviruses and identification of Traditional Chinese Medicine as potential origin of zoonotic coronaviruses
por: Wassenaar, T.M., et al.
Publicado: (2020)

Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CL (pro)) structure: virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates
por: Chen, Yu Wai, et al.
Publicado: (2020)

Mental health and a novel coronavirus (2019-nCoV) in China
por: Zheng, Wei
Publicado: (2020)

Response of ophthalmologists in Israel to the novel coronavirus (2019-nCoV) outbreak
por: Wasser, Lauren M., et al.
Publicado: (2020)

Machine intelligence design of 2019-nCoV drugs
por: Gao, Kaifu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fghlficsuaip22ftolo9d6sak7